Global External Neuromodulation Market By Product Type (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation) And By End-Users/Application (Spinal Cord Stimulation, Deep Brain Stimulation) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the External Neuromodulation market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on External Neuromodulation market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of External Neuromodulation industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the External Neuromodulation ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the External Neuromodulation market.

The following manufacturers are covered in this report:
  • Medtronic, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • St. Jude Medical, Inc. (U.S.)
  • Synapse Biomedical, Inc. (U.S.)
  • Nevro Corporation (U.S.)
  • Neurosigma, Inc. (U.S.)
  • Neuropace, Inc. (U.S.)
  • Neuronetics, Inc. (U.S.)
  • Cyberonics, Inc. (U.S.)
  • BioControl Medical (Israel)

The report estimates on the External Neuromodulation market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global External Neuromodulation market report consist of all leading industry players, External Neuromodulation business sections, company profile, revenue supply by External Neuromodulation industry sections, global External Neuromodulation market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the External Neuromodulation market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the External Neuromodulation market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on External Neuromodulation market, global analysis, different challenges or threats and opportunities for stakeholders involved in the External Neuromodulation market.

Report Opportunity: Global External Neuromodulation Market

This report delivers an analytical examination of the External Neuromodulation market summarized in broad sections such as
  1. External Neuromodulation Market Summary
  2. Key Commercial Growths in the External Neuromodulation Industry
  3. Market Dynamics Affecting the External Neuromodulation Industry
  4. Important Market Trends and Future Development Scenario of the External Neuromodulation Market
  5. External Neuromodulation Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of External Neuromodulation Industry
  7. Positioning of Main Market Players in the External Neuromodulation Industry
  8. External Neuromodulation Market Revenue and Forecast, by Application, 2018 - 2028
  9. External Neuromodulation Market Revenue and Forecast, by End-use, 2018 - 2028
  10. External Neuromodulation Market Revenue and Forecast, by Geography, 2018 - 2028
External Neuromodulation Market Segmentation:

The report provides detailed examination of the External Neuromodulation market on the basis of various segments such as type, application and end-use industry. The External Neuromodulation market is segmented as follows:

External Neuromodulation Market, by Type:
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Respiratory Electrical Stimulation
External Neuromodulation Market, by Application:
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Others
Geographic Coverage

The report on the External Neuromodulation market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America External Neuromodulation Market Revenue and Forecast
  • U.S.
  • Canada
Europe External Neuromodulation Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific External Neuromodulation Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America External Neuromodulation Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa External Neuromodulation Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global External Neuromodulation Market Snapshot
          2.1.1. Global External Neuromodulation Market By Type,2019
               2.1.1.1.Transcutaneous Electrical Nerve Stimulation
               2.1.1.2.Transcranial Magnetic Stimulation
               2.1.1.3.Respiratory Electrical Stimulation
          2.1.2. Global External Neuromodulation Market By Application,2019
               2.1.2.1.Spinal Cord Stimulation
               2.1.2.2.Deep Brain Stimulation
               2.1.2.3.Sacral Nerve Stimulation
               2.1.2.4.Others
          2.1.3. Global External Neuromodulation Market By End-use,2019
          2.1.4. Global External Neuromodulation Market By Geography,2019

3. Global External Neuromodulation Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global External Neuromodulation Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global External Neuromodulation Market Size (US$), By Type, 2018 – 2028

5. Global External Neuromodulation Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global External Neuromodulation Market Size (US$), By Application, 2018 – 2028

6. Global External Neuromodulation Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global External Neuromodulation Market Size (US$), By End-use, 2018 – 2028

7. Global External Neuromodulation Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America External Neuromodulation Market Analysis, 2018 – 2028 
          7.2.1. North America External Neuromodulation Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America External Neuromodulation Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America External Neuromodulation Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America External Neuromodulation Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe External Neuromodulation Market Analysis, 2018 – 2028 
          7.3.1.  Europe External Neuromodulation Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe External Neuromodulation Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe External Neuromodulation Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe External Neuromodulation Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific External Neuromodulation Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific External Neuromodulation Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific External Neuromodulation Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific External Neuromodulation Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific External Neuromodulation Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America External Neuromodulation Market Analysis, 2018 – 2028 
          7.5.1.  Latin America External Neuromodulation Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America External Neuromodulation Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America External Neuromodulation Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America External Neuromodulation Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) External Neuromodulation Market Analysis, 2018 – 2028 
          7.6.1.  MEA External Neuromodulation Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA External Neuromodulation Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA External Neuromodulation Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA External Neuromodulation Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key External Neuromodulation Providers
        8.4.1 Medtronic, Inc. (U.S.)
                8.1.1 Business Description
                8.1.2 Medtronic, Inc. (U.S.) Geographic Operations
                8.1.3 Medtronic, Inc. (U.S.) Financial Information
                8.1.4 Medtronic, Inc. (U.S.) Product Positions/Portfolio
                8.1.5 Medtronic, Inc. (U.S.) Key Developments
        8.4.2 Boston Scientific Corporation (U.S.)
                8.2.1 Business Description
                8.2.2 Boston Scientific Corporation (U.S.) Geographic Operations
                8.2.3 Boston Scientific Corporation (U.S.) Financial Information
                8.2.4 Boston Scientific Corporation (U.S.) Product Positions/Portfolio
                8.2.5 Boston Scientific Corporation (U.S.) Key Developments
        8.4.3 St. Jude Medical, Inc. (U.S.)
                8.3.1 Business Description
                8.3.2 St. Jude Medical, Inc. (U.S.) Geographic Operations
                8.3.3 St. Jude Medical, Inc. (U.S.) Financial Information
                8.3.4 St. Jude Medical, Inc. (U.S.) Product Positions/Portfolio
                8.3.5 St. Jude Medical, Inc. (U.S.) Key Developments
        8.4.4 Synapse Biomedical, Inc. (U.S.)
                8.4.1 Business Description
                8.4.2 Synapse Biomedical, Inc. (U.S.) Geographic Operations
                8.4.3 Synapse Biomedical, Inc. (U.S.) Financial Information
                8.4.4 Synapse Biomedical, Inc. (U.S.) Product Positions/Portfolio
                8.4.5 Synapse Biomedical, Inc. (U.S.) Key Developments
        8.4.5 Nevro Corporation (U.S.)
                8.5.1 Business Description
                8.5.2 Nevro Corporation (U.S.) Geographic Operations
                8.5.3 Nevro Corporation (U.S.) Financial Information
                8.5.4 Nevro Corporation (U.S.) Product Positions/Portfolio
                8.5.5 Nevro Corporation (U.S.) Key Developments
        8.4.6 Neurosigma, Inc. (U.S.)
                8.6.1 Business Description
                8.6.2 Neurosigma, Inc. (U.S.) Geographic Operations
                8.6.3 Neurosigma, Inc. (U.S.) Financial Information
                8.6.4 Neurosigma, Inc. (U.S.) Product Positions/Portfolio
                8.6.5 Neurosigma, Inc. (U.S.) Key Developments
        8.4.7 Neuropace, Inc. (U.S.)
                8.7.1 Business Description
                8.7.2 Neuropace, Inc. (U.S.) Geographic Operations
                8.7.3 Neuropace, Inc. (U.S.) Financial Information
                8.7.4 Neuropace, Inc. (U.S.) Product Positions/Portfolio
                8.7.5 Neuropace, Inc. (U.S.) Key Developments
        8.4.8 Neuronetics, Inc. (U.S.)
                8.8.1 Business Description
                8.8.2 Neuronetics, Inc. (U.S.) Geographic Operations
                8.8.3 Neuronetics, Inc. (U.S.) Financial Information
                8.8.4 Neuronetics, Inc. (U.S.) Product Positions/Portfolio
                8.8.5 Neuronetics, Inc. (U.S.) Key Developments
        8.4.9 Cyberonics, Inc. (U.S.)
                8.9.1 Business Description
                8.9.2 Cyberonics, Inc. (U.S.) Geographic Operations
                8.9.3 Cyberonics, Inc. (U.S.) Financial Information
                8.9.4 Cyberonics, Inc. (U.S.) Product Positions/Portfolio
                8.9.5 Cyberonics, Inc. (U.S.) Key Developments
        8.4.10 BioControl Medical (Israel)
                8.10.1 Business Description
                8.10.2 BioControl Medical (Israel) Geographic Operations
                8.10.3 BioControl Medical (Israel) Financial Information
                8.10.4 BioControl Medical (Israel) Product Positions/Portfolio
                8.10.5 BioControl Medical (Israel) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global External Neuromodulation Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America External Neuromodulation Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America External Neuromodulation Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America External Neuromodulation Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe External Neuromodulation Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe External Neuromodulation Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe External Neuromodulation Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific External Neuromodulation Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific External Neuromodulation Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific External Neuromodulation Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America External Neuromodulation Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America External Neuromodulation Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America External Neuromodulation Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA External Neuromodulation Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA External Neuromodulation Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA External Neuromodulation Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global External Neuromodulation: Market Segmentation 
FIG. 2 Global External Neuromodulation Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global External Neuromodulation Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global External Neuromodulation Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global External Neuromodulation Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global External Neuromodulation Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global External Neuromodulation Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key External Neuromodulation Providers, 2019
FIG. 11 Global External Neuromodulation Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global External Neuromodulation Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global External Neuromodulation Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America External Neuromodulation Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe External Neuromodulation Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific External Neuromodulation Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America External Neuromodulation Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA External Neuromodulation Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the External Neuromodulation market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1370

1040

OUR CLIENT